Skip to main content

Advertisement

Log in

ERAP1 and ERAP2 Gene Variations Influence the Risk of Psoriatic Arthritis in Romanian Population

  • Original Article
  • Published:
Archivum Immunologiae et Therapiae Experimentalis Aims and scope

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory disorder that belongs to the group of spondyloarthritis (SpA). It was found that single nucleotide polymorphisms (SNPs) of endoplasmic reticulum aminopeptidase (ERAP1 and ERAP2) genes influence the risk of ankylosing spondylitis, the most common form of SpA and the risk of psoriasis. Our purpose was to investigate the possible association of ERAP1 and ERAP2 gene SNPs with psoriatic arthritis susceptibility in Romanian population. Subsequent analyses included patients’ subgroups according to HLA-B27 status. Psoriatic arthritis patients (N = 98) and random healthy controls (N = 139) were genotyped for ERAP1/2 genes SNPs rs30187, rs27044, rs2910686, and rs2248374 by TaqMan Allelic Discrimination Assays. An additional control group (N = 108; 100% HLA-B27 positive) was used for subsequent analyses. The results showed the association of rs2248374 SNP of ERAP2 gene with the risk of PsA, especially for HLA-B27 negative disease (p = 0.02; OR 1.59). ERAP2 haplotype GT (rs2248374/rs2910686) was significantly under-represented in PsA patients than in controls (43 vs. 55%; p = 0.02). The analysis of ERAP1 SNPs in HLA-B27 positive controls and PsA subgroup showed strong evidence of association for rs30187 (p = 0.005; OR 2.73) and for CC rs30187/rs27044 haplotype (47% in patients vs. 70.5% in controls; p = 0.006). In conclusion, we found a significant association of ERAP2 with PsA and HLA-B27 negative PsA, while ERAP1 association was restricted only to HLA-B27 positive disease. To our knowledge, this is the first study that investigated ERAP2 polymorphisms in relation to PsA susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Andres AM, Dennis MY, Kretzschmar WW et al (2010) Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet 6:e1001157

    Article  PubMed  PubMed Central  Google Scholar 

  • Cherciu M, Popa LO, Bojinca M et al (2013) Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis. Tissue Antigens 82:192–196

    Article  CAS  PubMed  Google Scholar 

  • Cifaldi L, Romania P, Lorenzi S et al (2012) Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci 13:8338–8352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cortes A, Hadler J, Pointon JP et al (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45:730–738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Evans DM, Spencer CC, Pointon JJ et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43:761–767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Evnouchidou I, Kamal RP, Seregin SS et al (2011) Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 186:1909–1913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66–73

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jadon D, Tillett W, Wallis D et al (2013) Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology 52:261–266

    Article  CAS  PubMed  Google Scholar 

  • Julia A, Tortosa R, Hernanz JM et al (2012) Risk variants for psoriasis vulgaris in a large case–control collection and association with clinical subphenotypes. Hum Mol Genet 21:4549–4557

    Article  CAS  PubMed  Google Scholar 

  • Kenna TJ, Robinson PC, Haroon N (2015) Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Rheumatology 54:1549–1556

    Article  PubMed  Google Scholar 

  • Kim WY, Lee JB, Kim HY et al (2015) Endoplasmic reticulum aminopeptidase 2 is highly expressed in papillary thyroid microcarcinoma with cervical lymph node metastasis. J Cancer Res Ther 11:443–446

    Article  CAS  PubMed  Google Scholar 

  • Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharm Ther 35:680–689

    Google Scholar 

  • Mpakali A, Giastas P, Mathioudakis N et al (2015) Structural basis for antigenic peptide recognition and processing by endoplasmic reticulum (ER) aminopeptidase 2. J Biol Chem 290:26021–26032

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Rielly DD, Rahman P (2014) Genetics of psoriatic arthritis. Best Pract Res Clin Rheumatol 28:673–685

    Article  PubMed  Google Scholar 

  • Palmer JB, Li Y, Herrera V et al (2016) Treatment patterns and costs for anti-TNFalpha biologic therapy in patients with psoriatic arthritis. BMC Musculoskelet Disord 17:261

    Article  PubMed  PubMed Central  Google Scholar 

  • Popa OM, Bojinca M, Bojinca V et al (2010) Distribution of HLA-B27 in Romanian spondyloarthritides patients. Int J Immunogenet 37:513–516

    Article  CAS  PubMed  Google Scholar 

  • Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reeves E, Colebatch-Bourn A, Elliott T et al (2014) Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis. Proc Natl Acad Sci USA 111:17594–17599

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson PC, Costello ME, Leo P et al (2015) ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Ann Rheum Dis 74:1627–1629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strange A, Capon F, Spencer CC et al (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strom TM, Wienker TF (2016) DeFinetti program. http://ihg.gsf.de/cgi-bin/hw/hwa1.pl. Accessed 30 May 2016

  • Stuart PE, Nair RP, Tsoi LC et al (2015) Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet 97:816–836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tanioka T, Hattori A, Masuda S et al (2003) Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases. J Biol Chem 278:32275–32283

    Article  CAS  PubMed  Google Scholar 

  • Tsoi LC, Spain SL, Knight J et al (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341–1348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang Q, Liu H, Qu L et al (2013) Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. Br J Dermatol 168:1060–1065

    Article  CAS  PubMed  Google Scholar 

  • Yin X, Low HQ, Wang L et al (2015) Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun 6:6916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zervoudi E, Saridakis E, Birtley JR et al (2013) Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses. Proc Natl Acad Sci USA 110:19890–19895

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was supported by TC28350/2013 grant from Carol Davila University of Medicine and Pharmacy, Romania.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivia M. Popa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 58 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Popa, O.M., Cherciu, M., Cherciu, L.I. et al. ERAP1 and ERAP2 Gene Variations Influence the Risk of Psoriatic Arthritis in Romanian Population. Arch. Immunol. Ther. Exp. 64 (Suppl 1), 123–129 (2016). https://doi.org/10.1007/s00005-016-0444-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00005-016-0444-4

Keywords

Navigation